IDERA PHARMACEUTICALS

idera-pharmaceuticals-logo

Idera Pharmaceuticals, Inc., a biotechnology company, discovers and develops DNA- and RNA-based drug candidates for the treatment of infectious diseases, autoimmune and inflammatory diseases, cancer, and asthma and allergies, and for use as vaccine adjuvants. The company designs and creates proprietary Toll-Like Receptors (TLR) to modulate immune responses, including TLR agonist, a compound that stimulates an immune response through the targeted TLR; and TLR antagonist, a compound that blocks ac... tivation of an immune response through the targeted TLR. Its drug candidates include IMO-2125, a TLR9 agonist, which is in Phase 1 clinical trial for hepatitis C virus infection; and TLR7, 8, and 9 agonists that are in research stage for viral diseases. The company also develops IMO-3100, a dual TLR7/TLR9 antagonist, which is in preclinical development stage for autoimmune and inflammatory diseases, such as lupus, rheumatoid arthritis, multiple sclerosis, psoriasis, and colitis. In addition, its drug candidates also comprise TLR7 and TLR8 agonists that are in research stage for solid tumor cancers. The company has a licensing and collaboration agreement with Merck KGaA to research, develop, and commercialize TLR9 agonists for the treatment of cancer, excluding cancer vaccines; a license and research collaboration agreement with Merck & Co., Inc. to research, develop, and commercialize therapeutic and prophylactic vaccine products containing its TLR7, 8, and 9 agonists in the fields of cancer, infectious diseases, and Alzheimer's disease; and a research collaboration and option agreement, and a license, development, and commercialization agreement with Novartis International Pharmaceutical, Ltd. to discover, develop, and commercialize TLR9 agonists for the treatment of asthma and allergies. The company was founded in 1989 and is based in Cambridge, Massachusetts.

#SimilarOrganizations #People #Financial #Website #More

IDERA PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
1989-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.iderapharma.com

Total Employee:
51+

Status:
Active

Contact:
617-679-5500

Email Addresses:
[email protected]

Total Funding:
74.5 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Font Awesome


Similar Organizations

capella-bioscience-logo

Capella BioScience

Capella Bioscience engages in the discovery and development of monoclonal antibodies.

sunesis-pharmaceuticals-logo

Sunesis Pharmaceuticals

Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.


Current Advisors List

not_available_image

Mark Goldberg Board of Directors @ Idera Pharmaceuticals
Board_member
2014-01-01

not_available_image

Malcolm MacCoss Board of Directors @ Idera Pharmaceuticals
Board_member
2010-01-01

not_available_image

Abude Omari Board of Directors @ Idera Pharmaceuticals
Board_member
2012-01-01

not_available_image

William S. Reardon Board of Directors @ Idera Pharmaceuticals
Board_member
2002-01-01

james-geraghty_image

James Geraghty Chairman of the Board & Board of Directors @ Idera Pharmaceuticals
Board_member
2013-07-01

robert-karr_image

Robert Karr Board of Directors @ Idera Pharmaceuticals
Board_member
2005-06-01

not_available_image

Youssef El Zein Board of Directors @ Idera Pharmaceuticals
Board_member

not_available_image

Andrew D Luster Clinical Advisory Board @ Idera Pharmaceuticals
Advisor

Current Employees Featured

john-j-kirby_image

John J. Kirby
John J. Kirby Senior Vice President, Chief Financial Officer @ Idera Pharmaceuticals
Senior Vice President, Chief Financial Officer

robert-d-arbeit_image

Robert D. Arbeit
Robert D. Arbeit Vice President, Clinical Development @ Idera Pharmaceuticals
Vice President, Clinical Development
2009-01-01

louis-j-arcudi_image

Louis J. Arcudi
Louis J. Arcudi Senior Vice President of Operations, Chief Financial Officer, Treasurer, and Secretary @ Idera Pharmaceuticals
Senior Vice President of Operations, Chief Financial Officer, Treasurer, and Secretary

shah-rahimian_image

Shah Rahimian
Shah Rahimian Medical Director @ Idera Pharmaceuticals
Medical Director

louis-brenner_image

Louis Brenner
Louis Brenner Senior Vice President and Chief Medical Officer @ Idera Pharmaceuticals
Senior Vice President and Chief Medical Officer
2014-01-01

not_available_image

Daniel B. Soland
Daniel B. Soland Senior Vice President and Chief Operating Officer @ Idera Pharmaceuticals
Senior Vice President and Chief Operating Officer
2021-01-01

vincent-milano_image

Vincent Milano
Vincent Milano CEO @ Idera Pharmaceuticals
CEO
2014-12-01

timothy-m-sullivan_image

Timothy M. Sullivan
Timothy M. Sullivan Vice President, Development Programs and Alliance Management @ Idera Pharmaceuticals
Vice President, Development Programs and Alliance Management

Founder


sudhir-agrawal_image

Sudhir Agrawal

Stock Details


Company's stock symbol is FRA:HXXA

Investors List

merck-kgaa_image

Merck

Merck investment in Post-IPO Equity - Idera Pharmaceuticals

Official Site Inspections

http://www.iderapharma.com Semrush global rank: 3.25 M Semrush visits lastest month: 5.1 K

  • Host name: ec2-52-1-164-19.compute-1.amazonaws.com
  • IP address: 52.1.164.19
  • Location: Ashburn United States
  • Latitude: 39.0481
  • Longitude: -77.4728
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20149

Loading ...

More informations about "Idera Pharmaceuticals" on Search Engine